Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 6;8(4):280.
doi: 10.3390/children8040280.

Update on Acute Disseminated Encephalomyelitis in Children and Adolescents

Affiliations
Review

Update on Acute Disseminated Encephalomyelitis in Children and Adolescents

Serena Massa et al. Children (Basel). .

Abstract

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated, inflammatory demyelinating disease of the central nervous system (CNS) that usually affects children and young adults after an infection or vaccination. The presence of several conditions mimicking ADEM, added to the lack of specific biomarkers, makes diagnosis potentially hard. Prompt diagnosis is necessary to start adequate treatment to improve the clinical course and long-term outcome. Because of its heterogeneity in both clinical presentation and course, challenges remain in establishing the most appropriate therapeutic approach in each patient. The aim of this review is to provide an update on management of this disease with a focus on acute treatment and to give suggestions for future research. We showed that there are currently no guidelines that help clinicians manage ADEM and therapeutic decisions are often made on a case-by-case basis. Further studies are necessary to identify clinical, laboratory, and instrumental criteria that could be correlated with outcomes and guide clinicians in choosing when and what treatment should be given in each case.

Keywords: ADEM; acute disseminated encephalomyelitis; central nervous system; children; demyelinating disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Pathogenesis of acute disseminated encephalomyelitis (ADEM).
Figure 2
Figure 2
Diagnostic work-up in pediatric acute disseminated encephalomyelitis (ADEM). LP: lumbar puncture, BA: blood analysis, WM: white matter.
Figure 3
Figure 3
Therapeutic algorithm in pediatric acute disseminated encephalomyelitis (ADEM).

References

    1. Carlisi E., Pavese C., Mandrini S., Carenzio G., Toffola E.D. Early rehabilitative treatment for pediatric acute disseminated encephalomyelitis: Case report. Eur. J. Phys. Rehabil. Med. 2014;51:341–343. - PubMed
    1. Paolilo R.B., Deiva K., Neuteboom R., Rostásy K., Lim M. Acute Disseminated Encephalomyelitis: Current Perspectives. Children. 2020;7:210. doi: 10.3390/children7110210. - DOI - PMC - PubMed
    1. Matricardi S., Farello G., Savasta S., Verrotti A. Understanding Childhood Neuroimmune Diseases of the Central Nervous System. Front. Pediatr. 2019;7:511. doi: 10.3389/fped.2019.00511. - DOI - PMC - PubMed
    1. Cole J., Evans E., Mwangi M., Mar S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatr. Neurol. 2019;100:26–34. doi: 10.1016/j.pediatrneurol.2019.06.017. - DOI - PubMed
    1. Alper G. Acute Disseminated Encephalomyelitis. J. Child. Neurol. 2012;27:1408–1425. doi: 10.1177/0883073812455104. - DOI - PubMed

LinkOut - more resources